We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a ...

According to Hartman, chest wrinkles are also the most challenging to treat. This is because the skin is thinner there ...

According to NICE's Early Value Assessment (EVA) guidance on the technology, automated use of DERM "could result in more ...

NICE reviewed various technologies and recommended DERM as the only AI tool suitable for NHS use. It is the first dermatology ...

An AI-powered system for detecting potential skin cancer has been approved by NICE for use on the NHS for three years.

An artificial intelligence system for potential skin cancer has been conditionally recommended for use in the NHS for the next three years while further evidence is collected. The technology aims to ...

The National Institute for Health and Care Excellence (NICE) has officially backed a AI tool for detecting skin cancer, marking a major milestone in the use of AI to free up specialist clinician’s ...

Journey Medical (DERM) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Skin cancer checks will be carried out by AI using smartphones on the NHS. The National Institute for Health and Care Excellence (Nice) has backed the use of the technology to examine suspicious moles ...

Journey Medical (DERM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price ...